Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pace

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|April 29, 2009
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancyDavid Pace
Future Microbiology|December 8, 2010
Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adultsDavid Pace
Current Opinion in Molecular Therapeutics|January 15, 2010
MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infectionDavid Pace
Expert Opinion on Biological Therapy|September 21, 2012
Glycoconjugate vaccinesDavid Pace
The Journal of Infection|September 21, 2014
LeishmaniasisDavid Pace
Drugs|November 3, 2017
Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix<sup>®</sup>): A ReviewSohita Dhillon, David Pace
Expert Review of Anti-Infective Therapy|July 28, 2015
Leishmaniasis: diagnostic issues in EuropePaul Torpiano, David Pace
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 28, 2021
Is ethnicity an appropriate measure of health care marginalization? A systematic review and meta-analysis of the outcomes of diabetic foot ulceration in Aboriginal populationsDavid Isa, David Pace
Expert Opinion on Biological Therapy|December 16, 2014
Glycoconjugate vaccines: an updateMairi Vella, David Pace
Journal of Infection Prevention|January 11, 2021
MRSA colonisation rates on a neonatal and paediatric intensive care unitRebecca Borg, David Pace
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|April 29, 2009
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancyDavid Pace
Future Microbiology|December 8, 2010
Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adultsDavid Pace
Current Opinion in Molecular Therapeutics|January 15, 2010
MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infectionDavid Pace
Expert Opinion on Biological Therapy|September 21, 2012
Glycoconjugate vaccinesDavid Pace
The Journal of Infection|September 21, 2014
LeishmaniasisDavid Pace
Drugs|November 3, 2017
Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix<sup>®</sup>): A ReviewSohita Dhillon, David Pace
Expert Review of Anti-Infective Therapy|July 28, 2015
Leishmaniasis: diagnostic issues in EuropePaul Torpiano, David Pace
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 28, 2021
Is ethnicity an appropriate measure of health care marginalization? A systematic review and meta-analysis of the outcomes of diabetic foot ulceration in Aboriginal populationsDavid Isa, David Pace
Expert Opinion on Biological Therapy|December 16, 2014
Glycoconjugate vaccines: an updateMairi Vella, David Pace
Journal of Infection Prevention|January 11, 2021
MRSA colonisation rates on a neonatal and paediatric intensive care unitRebecca Borg, David Pace
Pageof 7